Journal
NATURE IMMUNOLOGY
Volume 9, Issue 6, Pages 641-649Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1610
Keywords
-
Categories
Funding
- Howard Hughes Medical Institute Funding Source: Medline
- NIAID NIH HHS [5 R01 AI033856, R37 AI033303-16, R01 AI065303-05, 5 R37 AI033303, R01 AI065303, R37 AI033303] Funding Source: Medline
Ask authors/readers for more resources
T(H)-17 cells are interleukin 17 (IL-17)-secreting CD4(+) T helper cells involved in autoimmune disease and mucosal immunity. In naive CD4(+) T cells from mice, IL-17 is expressed in response to a combination of IL-6 or IL-21 and transforming growth factor-beta (TGF-beta) and requires induction of the nuclear receptor ROR gamma t. It has been suggested that the differentiation of human TH-17 cells is independent of TGF-beta and thus differs fundamentally from that in mice. We show here that TGF-beta, IL-1 beta and IL-6, IL-21 or IL-23 in serum-free conditions were necessary and sufficient to induce IL-17 expression in naive human CD4(+) T cells from cord blood. TGF-beta upregulated ROR gamma t expression but simultaneously inhibited its ability to induce IL-17 expression. Inflammatory cytokines relieved this inhibition and increased ROR gamma t-directed IL-17 expression. Other gene products detected in T(H)-17 cells after ROR gamma t induction included the chemokine receptor CCR6, the IL-23 receptor, IL-17F and IL-26. Our studies identify ROR gamma t as having a central function in the differentiation of human TH-17 cells from naive CD4(+) T cells and suggest that similar cytokine pathways are involved in this process in mice and humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available